Neuphoria Therapeutics Inc.

NasdaqGM: NEUP · Healthcare

Positivity Index

#4,073 / 6,774

Global

#1,944 / 4,000

United States

Positivity Score

19,954

Rank→

PosiRed: 1 active red flag (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 18 Dec 2025 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Neuphoria Therapeutics Inc. — Overview & Financial Snapshot

Neuphoria Therapeutics Inc. (NasdaqGM: NEUP) is a Healthcare company, ranked #4,073 of 6,774 companies globally and #1,944 of 4,000 in United States on PositoAI, with a Positivity Score of 19,954. Its market capitalisation is ₹177.75 Cr ($18.83M), P/E ratio is -1.1 and P/B ratio is 0.77. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

What does Neuphoria Therapeutics Inc. do?

Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, develops novel allosteric ion channel modulators for patients with serious central nervous system disorders in Australia. Its lead product candidate is BNC210, an oral, proprietary, selective negative allosteric modulator of the alpha7 nicotinic…

What is Neuphoria Therapeutics Inc.'s P/E and P/B ratio?

Neuphoria Therapeutics Inc. has a P/E ratio of -1.1 and a P/B ratio of 0.77.

What is Neuphoria Therapeutics Inc.'s debt-to-equity ratio?

Neuphoria Therapeutics Inc. has a debt-to-equity ratio of 0.00.

How much does Neuphoria Therapeutics Inc. owe compared with what it owns?

Neuphoria Therapeutics Inc. owes $0.14 for every $1 it owns (balance sheet Jun 2026), which is low.

What is Neuphoria Therapeutics Inc.'s Positivity rank?

Neuphoria Therapeutics Inc. is ranked #4,073 of 6,774 companies globally and #1,944 of 4,000 in United States on PositoAI, with a Positivity Score of 19,954.

Does Neuphoria Therapeutics Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Neuphoria Therapeutics Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 18 Dec 2025). It has no yellow flags.

Where can I read the latest news about Neuphoria Therapeutics Inc.?

Recent headlines about Neuphoria Therapeutics Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Neuphoria Therapeutics Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Neuphoria Therapeutics Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.